Lv6
2500 积分 2021-07-29 加入
The history and promise of Treg cells
1天前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
3天前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
6天前
已完结
PD-1 Tumor Suppressor Signaling in T Cell Lymphomas
7天前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
7天前
已完结
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
8天前
已完结
Targeting CD39 in cancer
9天前
已完结
The road to resistance: EGFR mutation and cetuximab
14天前
已完结
A measuring method for occupancy of immune checkpoint inhibitors in the cell surface
16天前
已完结
Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma
17天前
已完结
皖公网安备34019202002308
